## Clinical Context This is a case of **prolonged latent phase** in a primigravida with spontaneous rupture of membranes (SROM). The patient has been in labour for 12 hours with minimal cervical progress (2 cm dilation). ## Management Algorithm ```mermaid flowchart TD A[SROM at term + labour]:::outcome --> B{Cervical progress?}:::decision B -->|Adequate progress| C[Continue labour support]:::action B -->|No progress after 12h| D{Fetal status?}:::decision D -->|Normal FHR + variability| E[Augment with oxytocin]:::action D -->|Abnormal FHR| F[Cesarean section]:::urgent E --> G{Progress achieved?}:::decision G -->|Yes| H[Vaginal delivery]:::outcome G -->|No progress after 4h| I[Cesarean for arrest disorder]:::action ``` ## Key Point **Oxytocin augmentation is the standard next step** in a patient with SROM, normal fetal status, and arrest of dilation in the latent phase. This follows the ACOG/WHO partograph principles for active management of labour. ## High-Yield Facts - **Latent phase arrest** in primigravida: defined as <2 cm/hour progress over ≥4 hours - **SROM management**: expectant management is acceptable for 12–24 hours if maternal and fetal status remain reassuring - **Augmentation criteria**: normal FHR pattern + no contraindications to vaginal delivery - **Reassessment interval**: 4 hours after oxytocin initiation is standard before escalating to cesarean ## Clinical Pearl In a primigravida with SROM and normal fetal status, **immediate cesarean for arrest of dilation is premature**. Augmentation with oxytocin is the evidence-based intermediate step that respects the patient's wish for vaginal delivery while ensuring maternal and fetal safety. ## Timing Note Cesarean section for arrest disorder is indicated only after **adequate trial of augmentation** (typically ≥4 hours of oxytocin with adequate contractions) without progress. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.